Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Freestyle Libre Flash Glucose Monitoring System: How It Has Improved Glycaemic Control for People With Type 1 Diabetes in Eastern Cheshire, Uk Publisher



Yadegarfar G1, 2 ; Anderson SG3 ; Khawaja Z4 ; Cortes G5 ; Leivesley K6 ; Metters A6 ; Horne L6 ; Steele T6 ; Heald AH1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. The School Of Medicine And Manchester Academic Health Sciences Centre, University Of Manchester, United Kingdom
  2. 2. Heart Failure Research Center, Cardiovascular Research Institute, School Of Public Health, Isfahan University Of Medical Sciences, Isfahan, Iran
  3. 3. University Of The West Indies, Cave Hill Campus Barbados, Barbados, Barbados
  4. 4. Department Of Diabetes And Endocrinology, Salford Royal Hospital, Salford, United Kingdom
  5. 5. High Speciality Regional Hospital Of Ixtapaluca, Mexico City, Mexico
  6. 6. Vernova Healthcare, Watersgreen Medical Centre, Macclesfield, United Kingdom

Source: Cardiovascular Endocrinology and Metabolism Published:2020


Abstract

Introduction Many people with type 1 diabetes continue to run high HbA1c levels with associated elevated risk of cardiovascular events and increased mortality. We describe here how use of the FreeStyle Libre flash monitor has improved the glycaemic control of many people with type 1 diabetes where the new technology has been intensively deployed. Methods We report the outcomes of 92 consecutive adults (18 years of age or more) with type 1 diabetes who have begun using the FreeStyle Libre flash glucose monitor in East Cheshire, UK. Initiation was with education and support from one of the diabetes specialist nurses. An HbA1c of 60 mmol/mol (7.6%) was taken as the threshold for suboptimal glycaemic control. Results The mean cohort age was 43 years for men and 39 years for women (overall range 17-83 years). In 92 consecutive users, HbA1c decreased by an average of 10.7 mmol/mol (0.98%) after 3 months, and by 16.1 mmol/mol (1.47%) after 6 months. There was also a narrowing of the distribution of HbA1c, with many fewer people running high HbA1c ≥80 mmol/mol (9.5%). After the 6-month follow-up, two 2/92 users did not wish to continue with the monitoring. Conclusion Flash glucose monitoring has great potential for the management of type 1 diabetes in the adult population and improving metabolic control/quality of life for people across the world. The technology provides significantly more data than the intermittent results obtained by traditional subcutaneous blood glucose monitoring, which may not capture intervals of extreme variability or nocturnal events. © 2020 Lippincott Williams and Wilkins. All rights reserved.
Other Related Docs
9. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
27. Glycemic Control Among Iranian People With Type 2 Diabetes: A Systematic Review and Meta-Analysis, International Journal of Diabetes in Developing Countries (2023)